Moors & Cabot’s Clorox CLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-3,347
| Closed | -$413K | – | 932 |
|
|
2025
Q3 | $413K | Sell |
3,347
-351
| -9% | -$43.6K | 0.02% | 579 |
|
|
2025
Q2 | $444K | Sell |
3,698
-189
| -5% | -$25.2K | 0.02% | 531 |
|
|
2025
Q1 | $572K | Sell |
3,887
-155
| -4% | -$23.7K | 0.03% | 447 |
|
|
2024
Q4 | $656K | Buy |
4,042
+395
| +11% | +$64.6K | 0.03% | 425 |
|
|
2024
Q3 | $594K | Sell |
3,647
-99
| -3% | -$14.7K | 0.03% | 449 |
|
|
2024
Q2 | $511K | Buy |
3,746
+905
| +32% | +$126K | 0.03% | 480 |
|
|
2024
Q1 | $435K | Sell |
2,841
-304
| -10% | -$45.4K | 0.02% | 543 |
|
|
2023
Q4 | $448K | Buy |
3,145
+416
| +15% | +$55.5K | 0.03% | 494 |
|
|
2023
Q3 | $358K | Hold |
2,729
| – | – | 0.02% | 541 |
|
|
2023
Q2 | $434K | Sell |
2,729
-6,918
| -72% | -$1.12M | 0.03% | 484 |
|
|
2023
Q1 | $1.53M | Sell |
9,647
-84
| -0.9% | -$12.6K | 0.1% | 196 |
|
|
2022
Q4 | $1.37M | Sell |
9,731
-401
| -4% | -$56.9K | 0.1% | 217 |
|
|
2022
Q3 | $1.3M | Sell |
10,132
-459
| -4% | -$66.2K | 0.1% | 207 |
|
|
2022
Q2 | $1.49M | Buy |
10,591
+497
| +5% | +$71K | 0.11% | 189 |
|
|
2022
Q1 | $1.4M | Buy |
10,094
+862
| +9% | +$132K | 0.09% | 222 |
|
|
2021
Q4 | $1.61M | Buy |
9,232
+848
| +10% | +$141K | 0.1% | 207 |
|
|
2021
Q3 | $1.39M | Buy |
8,384
+6,148
| +275% | +$1.06M | 0.09% | 220 |
|
|
2021
Q2 | $402K | Buy |
2,236
+493
| +28% | +$90K | 0.03% | 490 |
|
|
2021
Q1 | $336K | Sell |
1,743
-2,145
| -55% | -$413K | 0.03% | 499 |
|
|
2020
Q4 | $781K | Sell |
3,888
-196
| -5% | -$40.6K | 0.07% | 274 |
|
|
2020
Q3 | $859K | Sell |
4,084
-162
| -4% | -$36.1K | 0.08% | 233 |
|
|
2020
Q2 | $933K | Buy |
4,246
+1,020
| +32% | +$204K | 0.1% | 200 |
|
|
2020
Q1 | $556K | Buy |
3,226
+239
| +8% | +$39.5K | 0.08% | 230 |
|
|
2019
Q4 | $456K | Sell |
2,987
-421
| -12% | -$62.9K | 0.05% | 361 |
|
|
2019
Q3 | $516K | Buy |
3,408
+1,501
| +79% | +$237K | 0.06% | 321 |
|
|
2019
Q2 | $290K | Buy |
1,907
+259
| +16% | +$39.6K | 0.04% | 418 |
|
|
2019
Q1 | $263K | Sell |
1,648
-480
| -23% | -$74.5K | 0.04% | 424 |
|
|
2018
Q4 | $329K | Sell |
2,128
-1,157
| -35% | -$180K | 0.05% | 343 |
|
|
2018
Q3 | $494K | Sell |
3,285
-36
| -1% | -$5.11K | 0.06% | 310 |
|
|
2018
Q2 | $453K | Sell |
3,321
-669
| -17% | -$82.6K | 0.06% | 324 |
|
|
2018
Q1 | $531K | Buy |
3,990
+162
| +4% | +$21.8K | 0.07% | 313 |
|
|
2017
Q4 | $572K | Buy |
3,828
+372
| +11% | +$50.6K | 0.08% | 290 |
|
|
2017
Q3 | $452K | Buy |
3,456
+899
| +35% | +$121K | 0.07% | 324 |
|
|
2017
Q2 | $339K | Buy |
2,557
+30
| +1% | +$4.05K | 0.06% | 364 |
|
|
2017
Q1 | $340K | Sell |
2,527
-1,571
| -38% | -$204K | 0.06% | 357 |
|
|
2016
Q4 | $491K | Buy |
4,098
+955
| +30% | +$113K | 0.08% | 287 |
|
|
2016
Q3 | $397K | Buy |
3,143
+27
| +0.9% | +$3.54K | 0.07% | 315 |
|
|
2016
Q2 | $433K | Sell |
3,116
-1,148
| -27% | -$149K | 0.08% | 284 |
|
|
2016
Q1 | $540K | Sell |
4,264
-437
| -9% | -$55.5K | 0.1% | 244 |
|
|
2015
Q4 | $600K | Buy |
4,701
+1,519
| +48% | +$189K | 0.11% | 226 |
|
|
2015
Q3 | $372K | Buy |
3,182
+376
| +13% | +$42.2K | 0.07% | 312 |
|
|
2015
Q2 | $288K | Buy |
2,806
+62
| +2% | +$6.69K | 0.05% | 396 |
|
|
2015
Q1 | $303K | Sell |
2,744
-98
| -3% | -$10.6K | 0.05% | 383 |
|
|
2014
Q4 | $292K | Buy |
2,842
+486
| +21% | +$48.6K | 0.05% | 382 |
|
|
2014
Q3 | $230K | Sell |
2,356
-671
| -22% | -$60.7K | 0.04% | 440 |
|
|
2014
Q2 | $275K | Buy |
+3,027
| New | +$271K | 0.05% | 400 |
|
Other funds holding CLX
Moors & Cabot's CLX Position: Q4 2025 in Review
Moors & Cabot sold out of Clorox (CLX) in Q4 2025, closing a stake of 3,347 shares — an estimated $413K sold.
Moors & Cabot first reported a position in CLX in Q2 2014 and held it in 46 quarters. The position peaked at $1.61M in Q4 2021. 1,052 funds tracked by Wall St. Rank hold CLX as of Q4 2025.
- Moors & Cabot reported no remaining Clorox position as of Q4 2025 after selling out during the quarter.
- Moors & Cabot sold 3,347 Clorox shares in Q4 2025, an estimated $413K.
- Moors & Cabot first reported a position in Clorox in Q2 2014 and held it in 46 quarters.
- Moors & Cabot's Clorox position peaked at $1.61M in Q4 2021.
- 1,052 funds tracked by Wall St. Rank held Clorox as of Q4 2025.
Based on Moors & Cabot's 13F filing for Q4 2025, filed 10 Feb 2026.